首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1672714

體外診斷 (IVD) 市場：按產品類型、按測試類型、按應用、按最終用戶、按地區

In Vitro Diagnostics Ivd Market, By Product, By Test Type, By Application, By End User, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 262 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球體外診斷 (IVD) 市場規模預計為 1,267.3 億美元，預計到 2032 年將達到 1,970.6 億美元，2025 年至 2032 年的複合年成長率為 6.5%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	1267.3億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	6.50%	2032 年價值預測	1970.6億美元

數字。 2025 年體外診斷 (IVD)市場佔有率（按地區）

全球體外診斷 (IVD) 市場涉及測試血液、尿液和組織等生物樣本以檢測疾病。 IVD 技術能夠早期發現疾病，有助於及時進行臨床介入並改善患者的治療效果。市場成長的動力包括老年人口的成長、慢性病和感染疾病率的上升以及技術進步導致更準確的就地檢驗和分子診斷測試的發展。然而，一些國家對新產品核可的嚴格規定和不利的醫療改革阻礙了市場的成長。

市場動態：

全球體外診斷（IVD）市場的發展受到人口老化（他們更容易患慢性疾病）、癌症和糖尿病等文明病發病率上升以及人們對早期發現疾病的認知不斷提高的推動。技術進步促進了用於照護現場和家庭檢測的微型化和可攜式診斷平台的開發，這也是一個主要促進因素。然而，部分地區對新產品核准的嚴格監管準則和醫療保險的縮減對市場成長構成了威脅。此外，各國對先進分子診斷測試的報銷政策各不相同，限制了市場的成長。新興國家不斷成長的醫療支出帶來了豐厚的利潤機會。

本研究的主要特點

本報告對全球體外診斷 (IVD) 市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 (2025-2032) 的市場規模和復合年成長率。
它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
本報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球體外診斷（IVD）市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球體外診斷（IVD）藥品市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球體外診斷（IVD）市場的各種策略矩陣來促進決策。

Siemens Healthineers
Sysmex Corporation
Bio-Rad Laboratories
bioMerieux SA
Becton Dickinson, and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN NV
Arkray, Inc.
Nittobo Medical Co., Ltd.
Medical & Biological Laboratories Co., Ltd.
Miraca Holdings Inc.
Mizuho Medy Co., Ltd.
Thermo Fischer Scientific Inc
Diasorin
Agilent Technologies, Inc
Grifols SA
Wheel of Fortune
Analyst View
Coherent Opportunity Map

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI195

Global In Vitro Diagnostics Ivd Market is estimated to be valued at USD 126.73 Bn in 2025 and is expected to reach USD 197.06 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 126.73 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 197.06 Bn

Figure. In Vitro Diagnostics Ivd Market Share (%), By Region 2025

Global in-vitro diagnostics market involves the testing of biological samples such as blood, urine, tissues, and others for detection of diseases. IVD technologies allow early detection of diseases which helps in timely clinical intervention and improved patient outcomes. The market growth is driven by rising geriatric population, increasing prevalence of chronic and infectious diseases, technological advancements leading to development of more accurate point-of-care and molecular diagnostic tests. However, stringent regulations for new product approvals and unfavorable healthcare reforms in some countries hinders the market growth.

Market Dynamics:

Global in-vitro diagnostics market growth is driven by rising geriatric population who are more prone to chronic diseases, increasing incidence of lifestyle diseases such as cancer and diabetes, and growing awareness regarding early disease detection. Technological advancements have led to the development of miniaturized and portable diagnostic platforms for point-of-care and home-based testing, which is another major growth driver. However, stringent regulatory guidelines for approval of new diagnostic products and reduced healthcare coverage in some regions pose threat to the market growth. Furthermore, reimbursement policies for advanced molecular diagnostic tests vary across countries which restrains the market growth. Growing healthcare expenditure in emerging nations offers lucrative opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global in-vitro diagnostics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global in-vitro diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMerieux S.A., Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray Inc., Nittobo Medical Co. , Medical & Biological Laboratories Co. Ltd., Miraca Holdings Inc., Mizuho Medy Co. Ltd., Thermo Fischer Scientific Inc, Diasorin, Agilent Technologies, Inc, and Grifols SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market.

Market Segmentation

Product Type:
- Reagents & Kits
- Instruments
Test Type:
- Clinical Chemistry
- Immunoassay
- Hematology
- Molecular Diagnostics
- Microbiology
- Coagulation & Hemostasis Urinalysis
- Others
Application:
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Disorders
- Others
End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Siemens Healthineers
- Sysmex Corporation
- Bio-Rad Laboratories
- bioMerieux S.A.
- Becton Dickinson and Company
- Danaher Corporation
- Abbott Laboratories
- Hoffmann-la Roche Ltd
- QIAGEN N.V.
- Arkray Inc.
- Nittobo Medical Co.
- Medical & Biological Laboratories Co.
- Miraca Holdings Inc.
- Mizuho Medy Co. Ltd.
- Thermo Fischer Scientific Inc
- Diasorin
- Agilent Technologies, Inc
- Grifols SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Test Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
PEST Analysis

4. Global In-Vitro Diagnostics Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global In-Vitro Diagnostics Market, By Product, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Reagents & Kits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global In-Vitro Diagnostics Market, By Test Type, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Clinical Chemistry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Immunoassay
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Hematology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Molecular Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Microbiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Coagulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global In-Vitro Diagnostics Market, By Application, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Nephrology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global In-Vitro Diagnostics Market, By End User, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global In-Vitro Diagnostics Market, By Region, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa

10. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sysmex Corporation
Bio-Rad Laboratories
bioMerieux S.A.
Becton Dickinson, and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN N.V.
Arkray, Inc.
Nittobo Medical Co., Ltd.
Medical & Biological Laboratories Co., Ltd.
Miraca Holdings Inc.
Mizuho Medy Co., Ltd.
Thermo Fischer Scientific Inc
Diasorin
Agilent Technologies, Inc
Grifols SA
Wheel of Fortune
Analyst View
Coherent Opportunity Map